Population exposure-safety and exposure-efficacy analyses for rucaparib in patients (pts) with recurrent ovarian carcinoma (rOC) from Study 10 and ARIEL2 Meeting Abstract
| Authors: | Konecny, G. E.; Oza, A. M.; Tinker, A. V.; Oaknin, A.; Shapira-Frommer, R.; Ray-Coquard, I.; Aghajanian, C.; Coleman, R. L.; O'Malley, D. M.; Leary, A.; Chen, L. M.; Provencher, D.; Ma, L.; Brenton, J. D.; Castro, C. M.; Green, M.; Simmons, A. D.; Beltman, J.; Harding, T.; Goble, S.; Maloney, L.; Kristeleit, R.; McNeish, I. A.; Swisher, E. M.; Xiao, J. J. |
| Abstract Title: | Population exposure-safety and exposure-efficacy analyses for rucaparib in patients (pts) with recurrent ovarian carcinoma (rOC) from Study 10 and ARIEL2 |
| Meeting Title: | 51st Annual Meeting of the Society of Gynecologic Oncology (SGO) |
| Journal Title: | Gynecologic Oncology |
| Volume: | 159 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Mar 28-31 |
| Meeting Location: | Toronto, Canada |
| ISSN: | 0090-8258 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2020-10-01 |
| Start Page: | 92 |
| End Page: | 93 |
| Language: | English |
| ACCESSION: | WOS:000579556200186 |
| DOI: | 10.1016/j.ygyno.2020.05.078 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 190 -- This meeting was cancelled due to COVID-19 -- Source: Wos |
